ATEŞ, Ö. Et Al. 2015. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer. 2015 ASCO Annual Meeting , (Chşcago, United States Of America).

ATEŞ, Ö., BABACAN, T., SARICI, S. F., KERTMEN, N., Aslan, A., Akin, S., ... KARAKAŞ, Y.(2015). Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer . 2015 ASCO Annual Meeting, Chşcago, United States Of America

ATEŞ, ÖZTÜRK Et Al. "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer," 2015 ASCO Annual Meeting, Chşcago, United States Of America, 2015

ATEŞ, ÖZTÜRK Et Al. "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer." 2015 ASCO Annual Meeting , Chşcago, United States Of America, 2015

ATEŞ, Ö. Et Al. (2015) . "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer." 2015 ASCO Annual Meeting , Chşcago, United States Of America.

@conferencepaper{conferencepaper, author={ÖZTÜRK ATEŞ Et Al. }, title={Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer}, congress name={2015 ASCO Annual Meeting}, city={Chşcago}, country={United States Of America}, year={2015}}